The Challenges of First-in-Human Stem Cell Clinical Trials: What Does This Mean for Ethics and Institutional Review Boards? (2018)

First Author: Roger Alistair Barker
Attributed to:  The Pluripotent Stem Cells and Engineered Cell (PSEC) Hub funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/CAM.25966

Publication URI: http://dx.doi.org/10.17863/CAM.25966

Parent Publication: Apollo - University of Cambridge Repository